Systems and methods for treatment of prostatic tissue
A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transurethrally. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Methods associated with use of the prostate therapy system are also covered.
1. A prostate ablation system, comprising:
a vapor generator; and
a vapor delivery probe operatively coupled to the vapor generator and adapted to be inserted transurethrally into a prostate adjacent to a prostatic urethra of a patient, the vapor delivery probe adapted to deliver condensable vapor from the vapor generator into the prostate to deliver between 100 and 10,000 Joules to the prostate to ablate the prostate without ablating the prostatic urethra.
2. The system of claim 1 wherein the vapor generator is disposed within the vapor delivery probe.
3. The system of claim 2 wherein the vapor generator is disposed within a handle of the vapor delivery probe.
4. The system of claim 1 wherein the vapor delivery probe further comprises a vapor needle configured to be advanced through the prostatic urethra into the prostate.
5. The system of claim 4 wherein the vapor needle comprises a plurality of vapor ports configured to deliver condensable vapor to the prostate.
6. The system of claim 4 wherein the vapor needle is coupled to an actuation mechanism configured to advance the vapor needle through the prostatic urethra into the prostate.
7. The system of claim 6 wherein the actuation mechanism is configured to advance the vapor needle into an apex of the prostate.
8. The system of claim 7 wherein the actuation mechanism is configured to advance the vapor needle at least 15 mm into the prostate.
9. The system of claim 6 wherein the actuation mechanism is manually controlled.
10. The system of claim 9 wherein the manually controlled actuation mechanism comprises a spring-loaded mechanism.
11. The system of claim 10 further comprising a lever on a handle of the vapor delivery probe configured to actuate the spring-loaded mechanism.
12. The system of claim 6 wherein the actuation mechanism is computer controlled.
13. The system of claim 1 wherein the condensable vapor undergoes a phase change after it is delivered to the prostate.
14. The system of claim 1 wherein the condensable vapor delivers between 100 W and 400 W to the prostate.
15. The system of claim 1 wherein the condensable vapor delivers between 250 cal/gm and 450 cal/gm to the prostate.
16. The system of claim 1 wherein the condensable vapor delivers between 20 W and 100 W to the prostate.
17. The system of claim 1 wherein the condensable vapor delivers between 100 cal/gm and 600 cal/gm to the prostate.